Hypertension treatment may slow down Alzheimer's progression
Researchers have found that nilvadipine, a drug that doctors regularly use to treat hypertension, may help people with Alzheimer's disease by increasing blood flow to the brain.
Alzheimer's disease is the most common form of dementia. This progressive disorder causes the degeneration and, ultimately, the death of brain cells.
People with dementia experience cognitive decline, and have issues making judgments and performing everyday tasks.
Dementia affects millions of people worldwide. According to Alzheimer's Disease International, the number of people with dementia was close to 50 million in 2017, and the organization say this number will almost double every 20 years, reaching 75 million people by 2030.
In the United States, Alzheimer's disease is the sixth leading cause of death.
Researchers have been looking for treatments to slow the progression of the disorder and recently found that the hypertension drug nilvadipine may have positive effects on the cerebral blood flow of those with Alzheimer's disease. The results appear in the journal Hypertension.